Dominick Angiolillo
Latest contributions
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
Post PCI anti-thrombotic strategies
15 May 2024 – From EuroPCR 2024
These papers changed my practice!
18 May 2023 – From EuroPCR 2023
Consult this session if you want to reflect on practical teachings from key papers of leading journals in 2022, to watch real cases translating science into practice, and to meet the editors of EuroIntervention and JACC: Cardiovascular Interventions.
How to optimise peri-PCI antiplatelet treatment in clinical practice? Novel evidence on cangrelor
17 May 2023 – From EuroPCR 2023
Discover the optimal approach to peri-percutaneous coronary intervention (PCI) antiplatelet treatment in clinical practice with a focus on the novel agent cangrelor. Gain a deeper understanding of the rationale behind cangrelor's use in various PCI settings, learn about the current recommendations and practices for its administration...
PCR Spotlight: antithrombotic and anticoagulant treatment in the COVID-19 era
18 May 2020
D Capodanno, G Montalescot, and D Angiolillo discuss how to manage antithrombotic therapy in patients with COVID-19 undergoing interventional procedures.
